Atlas Trials

Seroprevalence Study to Evaluate the Persistence of Anti-leptospira Antibody in Subjects Vaccinated With Spirolept® Vaccine

Clinical trial NCT03497572 · COMPLETED

Trial details

NCT number
NCT03497572
Sponsor
Imaxio
Status
COMPLETED
Study type
OBSERVATIONAL
Leptospirosis
Start date
2017-08-25
Primary completion
2018-04-12
Enrollment
145

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.